This webinar will focus on how ImmunoScape used high-dimensional, mass cytometry-based immunophenotyping of circulating lymphocytes to compare phenotypic expression across patients and timepoints, and correlate these with post-RT tumor responses. An expansion in...
This webinar will focus on immunoSCAPE’s signature assay, TargetScape, to identify and profile the immune response. Dr. Simoni will overview the technology and then focus on specific case studies from recent publications. Our presenter is Dr. Yannick Simoni,...
immunoSCAPE has the technology to deeply profile multifaceted T cell responses during pathogen infection that may be important for defining both the correlates of protective immunity, and to also identify potentially protective epitopes for incorporation into...
High-dimensional immunoprofiling can rationally inform how immunotherapy treatments and vaccines affect and modulate the immune response over time by identifying and quantifying large numbers of different immune cell subsets within blood or tissue samples. To learn...
